当前位置:
X-MOL 学术
›
Asian Pac. J. Allergy Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Regulatory T cell and cytokine changes in children undergoing 3 days rush venom immunotherapy.
Asian Pacific Journal of Allergy and Immunology ( IF 2.3 ) Pub Date : 2020-10-17 , DOI: 10.12932/ap-140520-0843 Tipyapa Rattanamanee 1 , Putthapoom Lumjiaktase 2 , Nanthisa Kemawichanura 2 , Potjanee Kiewgnam 1 , Wanlapa Jotikasthira 1 , Wiparat Manuyakorn 1
Asian Pacific Journal of Allergy and Immunology ( IF 2.3 ) Pub Date : 2020-10-17 , DOI: 10.12932/ap-140520-0843 Tipyapa Rattanamanee 1 , Putthapoom Lumjiaktase 2 , Nanthisa Kemawichanura 2 , Potjanee Kiewgnam 1 , Wanlapa Jotikasthira 1 , Wiparat Manuyakorn 1
Affiliation
Rush venom immunotherapy (VIT) is the recommended treatment for patients with Hymenoptera anaphylaxis. Specific data regarding regulatory T cell and cytokine changes in children receiving rush VIT are sparse.
中文翻译:
接受 3 天灯刺毒液免疫治疗的儿童中调节性 T 细胞和细胞因子的变化。
灯芯草毒液免疫疗法(VIT)是膜翅目过敏症患者的推荐治疗方法。有关接受 Rush VIT 的儿童中调节性 T 细胞和细胞因子变化的具体数据很少。
更新日期:2020-10-21
中文翻译:
接受 3 天灯刺毒液免疫治疗的儿童中调节性 T 细胞和细胞因子的变化。
灯芯草毒液免疫疗法(VIT)是膜翅目过敏症患者的推荐治疗方法。有关接受 Rush VIT 的儿童中调节性 T 细胞和细胞因子变化的具体数据很少。